Rockville, MD, October 13, 2016 – The number of deaths from tuberculosis (TB) is significantly higher than previously reported, according to the World Health Organization (WHO), which released updated figures in the annual update to its Global Tuberculosis Report today.
Rockville, MD, September 28, 2016 –Aeras has launched the AerasSHARE Biorepository, a new website to allow researchers from other organizations to access specimens and datasets that were collected by Aeras and its research partners in an effort to facilitate state-of-the-art TB vaccine related science and promote world-wide collaboration among TB vaccine researchers.
Rockville, MD, June 16, 2016 – The Sanofi Pasteur-Aeras Joint Steering Committee for the Phase 2 trial (C-040-404/TUB09) convened on 14 June 2016 to review and discuss the recommendations of the study’s independent Data Monitoring Committee (DMC).
Aeras applauds the Final Report and Recommendations released this week by the U.K. Review on Antimicrobial Resistance (Review) that highlights the extreme global health threat of antimicrobial resistance (AMR), including the threat of multidrug-resistant tuberculosis (MDR-TB).
Healthcare Workers Face Up To Six Times the Risk of Drug-Resistant Tuberculosis as General Population
New research suggests urgent action needed to combat tuberculosis among healthcare workers in poorer countries Globally, healthcare workers face three times the risk of contracting tuberculosis as the general population, and the risks of multidrug-resistant disease is higher still: up to six times higher for healthcare workers in South Africa, according to new reports that are part of a healthcare worker-focused supplement in the journal Clinical Infectious Diseases. Up to one-third of affected healthcare workers die of this airborne disease.